title: Famotidine in the management of gastro-oesophageal reflux.
abstract: Famotidine has been used for the treatment of peptic ulcers and Zollinger Ellison syndrome and is also useful in reflux and erosive oesophagitis. To evaluate the effects of Famotidine 20 mg given twice daily in the symptomatic relief of gastro-oesophageal reflux disease with normal oesophagus or mild endoscopic oesophagitis, patients were followed over a period of six weeks. 70% of the patients had complete day-time heartburn relief during the study and 75% had complete night-time heartburn relief during the study. Famotidine was found to be safe and there were no serious clinical or laboratory adverse experiences.
authors.affiliation: Kenya Medical Research Institute, (KEMRI), Nairobi.
authors.forename: F A
authors.initials: FA
authors.lastname: Okoth
authors.forename: G N
authors.initials: GN
authors.lastname: Lule
authors.forename: E O
authors.initials: EO
authors.lastname: Ogutu
authors.forename: S
authors.initials: S
authors.lastname: Pilczer
authors.forename: C
authors.initials: C
authors.lastname: Dubois
mesh_terms: D000328:Adult; D016099:Endoscopy, Gastrointestinal; D004942:Esophagitis, Peptic / Q000209:etiology; D015738:Famotidine / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D005764:Gastroesophageal Reflux / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D015738:Famotidine